Literature DB >> 22809680

How country-specific should a country-specific cost-effectiveness analysis be?

Shelby D Reed.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22809680     DOI: 10.1093/eurheartj/ehs204

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany.

Authors:  Martin Krejczy; Job Harenberg; Martin Wehling; Konrad Obermann; Gregory Y H Lip
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

2.  Challenges from Variation across Regions in Cost Effectiveness Analysis in Multi-Regional Clinical Trials.

Authors:  Yunbo Chu; Luyan Dai; Sheng Qi; Matthew Lee Smith; Hui Huang; Yang Li; Ye Shen
Journal:  Front Pharmacol       Date:  2016-10-28       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.